Fulcrum Therapeutics, Inc.
FULC
7 insider filings · Latest: Apr 23, 2026
Common Stock Transactions
| Txn Date | Accepted | Insider | Type | Shares | Avg Price | Value | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|---|
| Jan 2, 2026 | Feb 4 9:15 PM | Robert J GouldDirector | Sale | 15,000 | $10.87 | $163.1K | 469,864(D) | View → |
| Feb 2, 2026 | Feb 4 9:10 PM | Robert J GouldDirector | Sale | 15,000 | $10.72 | $160.9K | 454,864(D) | View → |
| Dec 15, 2025 | Dec 15 9:32 PM | CURTIS G OLTMANS | Proposed Sale | 3,452 | $13.00 | $44.9K | — | View → |
| Dec 8, 2025 | Dec 8 10:40 PM | RA Capital Healthcare Fund LP | Proposed Sale | 4,175,139 | $12.99 | $54.2M | — | View → |
| Nov 19, 2025 | Nov 19 9:20 PM | ROBERT J GOULD | Proposed Sale | 45,000 | $9.73 | $437.9K | — | View → |
Stock Options & Derivatives
| Txn Date | Accepted | Insider | Type | Shares | Exercise Price | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|
| Apr 23, 2026 | May 1 8:15 PM | Joshua Lehrer-GraiwerDirector | Grant/Award | 64,000 | $8.08 | 64,000(D) | View → |
| Feb 2, 2026 | Feb 4 9:10 PM | Alan A MussoChief Financial Officer | Grant/Award | 170,000 | $10.72 | 170,000(D) | View → |
| Feb 2, 2026 | Feb 4 9:10 PM | Curtis Gale OltmansChief Legal Officer | Grant/Award | 170,000 | $10.72 | 170,000(D) | View → |
| Feb 2, 2026 | Feb 4 9:10 PM | Greg TourangeauPrincipal Accounting Officer | Grant/Award | 57,000 | $10.72 | 57,000(D) | View → |
| Feb 2, 2026 | Feb 4 9:10 PM | Alex SapirDirector, President & Chief Executive Officer | Grant/Award | 650,000 | $10.72 | 650,000(D) | View → |